{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:28:43Z","timestamp":1793957323341,"version":"4.8.0"},"reference-count":42,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T00:00:00Z","timestamp":1648944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Antimicrobial resistance (AMR) is one of the key threats to global health and requires sustainable and effective actions to reduce its consequences in the near future worldwide. There are several well-documented and epidemiologically supported examples that both bacterial and viral vaccines might have an impact on AMR. Here, we conducted an ecological analysis of Italian data to evaluate the relationship between influenza vaccination coverage and AMR proportions over the last two decades. We found significant negative correlations between influenza vaccination coverage in the population over 64 years and AMR in Escherichia coli and Klebsiella pneumoniae isolates. The observed inverse relationships were confirmed by linear regression analysis. Similar results were obtained for the vaccination coverage in the overall population. Despite the main limitations of our study, its findings suggested an inverse relationship between influenza vaccination coverage and AMR proportions over the years, which was in accordance with previous theories illustrating how influenza vaccination reduced antibiotic prescriptions. However, since our study did not allow for us to elucidate the mechanisms underpinning the observed relationship, more and better data on confounding and mediating factors should be considered in future research.<\/jats:p>","DOI":"10.3390\/vaccines10040554","type":"journal-article","created":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:04:01Z","timestamp":1648965841000},"page":"554","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Inverse Relationship between Influenza Vaccination and Antimicrobial Resistance: An Ecological Analysis of Italian Data"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0905-5003","authenticated-orcid":false,"given":"Martina","family":"Barchitta","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences and Advanced Technologies \u201cGF Ingrassia\u201d, University of Catania, Via S. Sofia 87, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2655-8574","authenticated-orcid":false,"given":"Andrea","family":"Maugeri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences and Advanced Technologies \u201cGF Ingrassia\u201d, University of Catania, Via S. Sofia 87, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Vinci","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences and Advanced Technologies \u201cGF Ingrassia\u201d, University of Catania, Via S. Sofia 87, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4405-8162","authenticated-orcid":false,"given":"Antonella","family":"Agodi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences and Advanced Technologies \u201cGF Ingrassia\u201d, University of Catania, Via S. Sofia 87, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nm.4465","article-title":"The role of vaccines in preventing bacterial antimicrobial resistance","volume":"24","author":"Jansen","year":"2018","journal-title":"Nat. Med."},{"key":"ref_3","unstructured":"European Centre for Disease Prevention and Control (2022, February 01). Antimicrobial Resistance Surveillance in Europe 2022\u20132020 Data, Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2022-2020-data."},{"key":"ref_4","unstructured":"Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629\u2013655."},{"key":"ref_5","unstructured":"World Health Organization (2022, February 01). Ten Threats to Global Health in 2019. Available online: https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019."},{"key":"ref_6","unstructured":"World Health Organization (2022, February 01). One Health Global Leaders Group on Antimicrobial Resistance. Available online: https:\/\/www.who.int\/news-room\/articles-detail\/one-health-global-leaders-group-on-antimicrobial-resistance."},{"key":"ref_7","unstructured":"World Health Organization (2022, February 01). Antimicrobial Resistance: Invest in Innovation and Research, and Boost R&D and Access 2018. Available online: https:\/\/www.who.int\/antimicrobial-resistance\/interagency-coordination-group\/IACG_AMR_Invest_innovation_research_boost_RD_and_access_110618.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Barchitta, M., Quattrocchi, A., Maugeri, A., La Rosa, M.C., La Mastra, C., Sessa, L., Cananzi, P., Murolo, G., Oteri, A., and Basile, G. (2019). Antibiotic Consumption and Resistance during a 3-Year Period in Sicily, Southern Italy. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16132253"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Newitt, S., Oloyede, O., Puleston, R., Hopkins, S., and Ashiru-Oredope, D. (2019). Demographic, Knowledge and Impact Analysis of 57,627 Antibiotic Guardians Who Have Pledged to Contribute to Tackling Antimicrobial Resistance. Antibiotic, 8.","DOI":"10.3390\/antibiotics8010021"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Chaintarli, K., Ingle, S.M., Bhattacharya, A., Ashiru-Oredope, D., Oliver, I., and Gobin, M. (2016). Impact of a United Kingdom-wide campaign to tackle antimicrobial resistance on self-reported knowledge and behaviour change. BMC Public Health, 16.","DOI":"10.1186\/s12889-016-3057-2"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/dkv310","article-title":"A systematic review of the public\u2019s knowledge and beliefs about antibiotic resistance","volume":"71","author":"McCullough","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Barchitta, M., Quattrocchi, A., Maugeri, A., Rosa, M.C., Mastra, C., Basile, G., Giuffrida, G., Rinaldi, F.M., Murolo, G., and Agodi, A. (2020). The \u201cObiettivo Antibiotico\u201d Campaign on Prudent Use of Antibiotics in Sicily, Italy: The Pilot Phase. Int. J. Env. Res. Public Health, 17.","DOI":"10.3390\/ijerph17093077"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13756-021-01002-w","article-title":"Knowledge, attitudes and behaviors on antibiotic use and resistance among healthcare workers in Italy, 2019: Investigation by a clustering method","volume":"10","author":"Barchitta","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_14","first-page":"1","article-title":"Hospital Hygiene and Infection Prevention and Control in Italy: State of the art and perspectives","volume":"30","author":"Brusaferro","year":"2018","journal-title":"Ann. Ig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1016\/j.sjbs.2021.08.054","article-title":"The role of vaccines in combating antimicrobial resistance (AMR) bacteria","volume":"28","author":"Alghamdi","year":"2021","journal-title":"Saudi. J. Biol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The role of vaccines in combatting antimicrobial resistance","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1073\/pnas.1721095115","article-title":"Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects","volume":"115","author":"Klugman","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1007\/s10311-021-01274-z","article-title":"The impact of human vaccines on bacterial antimicrobial resistance. A review","volume":"19","author":"Jansen","year":"2021","journal-title":"Env. Chem. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/14760584.2018.1525298","article-title":"Influenza vaccination and prevention of antimicrobial resistance","volume":"17","author":"Esposito","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e1176","DOI":"10.1016\/S2214-109X(17)30364-9","article-title":"Vaccination to reduce antimicrobial resistance","volume":"5","author":"Ginsburg","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"ref_21","unstructured":"World Health Organization (2022, February 01). Influenza Vaccination Coverage and Effectiveness. Available online: https:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/influenza\/vaccination\/influenza-vaccination-coverage-and-effectiveness."},{"key":"ref_22","unstructured":"European Centre for Disease Prevention and Control (2022, February 01). ECDC Country Visit to Italy to Discuss Antimicrobial Resistance Issues, Available online: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AMR-country-visit-Italy.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Barchitta, M., Maugeri, A., La Rosa, M.C., La Mastra, C., Murolo, G., Corrao, G., and Agodi, A. (2021). Burden of Healthcare-Associated Infections in Sicily, Italy: Estimates from the Regional Point Prevalence Surveys 2016\u20132018. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111360"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Barchitta, M., Maugeri, A., La Rosa, M.C., La Mastra, C., Murolo, G., and Agodi, A. (2020). Three-Year Trends of Healthcare-Associated Infections and Antibiotic Use in Acute Care Hospitals: Findings from 2016\u20132018 Point Prevalence Surveys in Sicily, Italy. Antibiotics, 10.","DOI":"10.3390\/antibiotics10010001"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"ckaa165.175","DOI":"10.1093\/eurpub\/ckaa165.175","article-title":"Burden of Healthcare-Associated Infections in Italy: Disability-Adjusted Life Years","volume":"30","author":"Bordino","year":"2020","journal-title":"Eur. J. Public Health"},{"key":"ref_26","unstructured":"(2018). Secondo Studio di Prevalenza Italiano sulle Infezioni Correlate All\u2019assistenza e sull\u2019uso di Antibiotici Negli Ospedali per Acuti\u2013Protocollo ECDC, Dipartimento Scienze della Salute Pubblica e Pediatriche, Universit\u00e0 di Torino."},{"key":"ref_27","unstructured":"Italian National Institute of Health (2022, February 01). Coperture Della Vaccinazione Antinfluenzale in ITALIA, Available online: https:\/\/www.epicentro.iss.it\/influenza\/coperture-vaccinali."},{"key":"ref_28","unstructured":"Italian Ministry of Health (2022, February 01). Influenza Vaccination, Available online: https:\/\/www.salute.gov.it\/portale\/influenza\/dettaglioContenutiInfluenza.jsp?id=686&area=influenza&menu=vuoto&tab=1."},{"key":"ref_29","first-page":"77","article-title":"Immunisation Registries at regional level in Italy and the roadmap for a future Italian National Registry","volume":"30","author":"Gianfredi","year":"2018","journal-title":"Ann. Ig."},{"key":"ref_30","first-page":"95","article-title":"Antibiotic-resistance in Italy: Activity of the first year of the surveillance project AR-ISS","volume":"17","author":"Boccia","year":"2005","journal-title":"Ann. Ig."},{"key":"ref_31","unstructured":"Italian National Institute of Health (2022, February 01). AR-ISS: Sorveglianza Nazionale dell\u2019Antibiotico-Resistenza, Available online: https:\/\/www.epicentro.iss.it\/antibiotico-resistenza\/ar-iss\/RIS-1_2021.pdf."},{"key":"ref_32","unstructured":"European Centre for Disease Prevention and Control (2022, February 01). Surveillance Atlas of Infectious Diseases, Available online: https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx."},{"key":"ref_33","unstructured":"Italian Medicines Agency (2022, February 01). L\u2019uso Degli Antibiotici in Italia. Rapporto Nazionale, Available online: https:\/\/www.aifa.gov.it\/documents\/20142\/1283180\/Rapporto_Antibiotici_2019.pdf."},{"key":"ref_34","unstructured":"(2022, February 01). Italian National Institute of Statistics. Available online: https:\/\/www.istat.it\/en\/."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.ajpath.2014.08.030","article-title":"The role of viral, host, and secondary bacterial factors in influenza pathogenesis","volume":"185","author":"Kash","year":"2015","journal-title":"Am. J. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/01.inf.0000217370.83948.51","article-title":"Effectiveness of inactivated influenza vaccine for prevention of otitis media in children","volume":"25","author":"Ozgur","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010\u20132011","volume":"315","author":"Hersh","year":"2016","journal-title":"JAMA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/605087","article-title":"The effect of universal influenza immunization on antibiotic prescriptions: An ecological study","volume":"49","author":"Kwong","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Dbaibo, G. (2017, January 23\u201327). Inactivated quadrivalent influenza vaccine reduces influenza associated healthcare, antibiotic use and parent-child absenteeism during a randomized controlled trial in healthy children aged 6\u201335 months. Proceedings of the 35th Meeting of the European Society for Paediatric Infectious Diseases, Madrid, Spain.","DOI":"10.26226\/morressier.58fa1765d462b80290b50b0e"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1016\/j.vaccine.2021.09.069","article-title":"Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England","volume":"39","author":"Sinnathamby","year":"2021","journal-title":"Vaccine"},{"key":"ref_41","unstructured":"Global Influenza Initiative Work Stream II Team (2022, February 01). Influenza Vaccination and Antimicrobial Resistance: Strategic Recommendations. Available online: https:\/\/www.nivel.nl\/sites\/default\/files\/bestanden\/1003995.pdf39."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"g2979","DOI":"10.1136\/bmj.g2979","article-title":"Ecological studies: Advantages and disadvantages","volume":"348","author":"Sedgwick","year":"2014","journal-title":"BMJ Br. Med. J."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/4\/554\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:49:18Z","timestamp":1760136558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/4\/554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,3]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["vaccines10040554"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10040554","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,3]]}}}